Vancouver’s Rakovina Therapeutics (RKV:TSXV) is a Canadian biotechnology company focused on developing innovative therapies for the treatment of cancer. It was founded in 2021 by Jeffrey Bacha, a serial entrepreneur with startups and companies operating in the biotechnology and life sciences fields. Earlier this year, Bacha and the Rakovina team made a strategic pivot as […]
Rakovina Therapeutics
Rakovina Therapeutics Advances AI in Cancer Drug Research
Vancouver’s Rakovina Therapeutics is evolving their business model to place the biopharmaceutical company at the forefront of artificial intelligence-driven (AI) precision medicine for cancer drug development research. Dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, Rakovina has entered into a collaboration agreement with Dr. Artem Cherkasov […]